Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs.
CD4+ T cell
HLA class II
NFAT-GFP reporter
TCR
TCR-T therapy
WT1
Journal
Cancer immunology, immunotherapy : CII
ISSN: 1432-0851
Titre abrégé: Cancer Immunol Immunother
Pays: Germany
ID NLM: 8605732
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
13
12
2022
accepted:
01
03
2023
medline:
15
6
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
ppublish
Résumé
CD4
Identifiants
pubmed: 36939853
doi: 10.1007/s00262-023-03420-8
pii: 10.1007/s00262-023-03420-8
pmc: PMC10264488
doi:
Substances chimiques
Receptors, Antigen, T-Cell
0
Antigens, Neoplasm
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2347-2356Subventions
Organisme : Japan Society for the Promotion of Science
ID : 17K07215
Organisme : Japan Society for the Promotion of Science
ID : 17K07216
Organisme : Japan Society for the Promotion of Science
ID : 19K07729
Informations de copyright
© 2023. The Author(s).
Références
Immunology. 2009 Feb;126(2):165-76
pubmed: 19125887
J Clin Invest. 2019 Jan 2;129(1):324-335
pubmed: 30530988
Blood. 2011 Sep 29;118(13):3528-37
pubmed: 21750319
Anticancer Res. 2015 Mar;35(3):1251-61
pubmed: 25750272
J Immunother Cancer. 2020 May;8(1):
pubmed: 32448802
Exp Hematol. 2005 Jul;33(7):811-8
pubmed: 15963857
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6973-8
pubmed: 23576742
Anticancer Res. 2012 Dec;32(12):5201-9
pubmed: 23225417
J Mol Biol. 2005 Feb 11;346(1):223-39
pubmed: 15663940
Nat Commun. 2012 Jul 10;3:948
pubmed: 22781761
Nature. 2005 Mar 3;434(7029):88-93
pubmed: 15744305
Sci Transl Med. 2015 Aug 19;7(301):301ra131
pubmed: 26290413
J Immunother. 2007 Apr;30(3):282-93
pubmed: 17414319
J Immunother. 2013 Apr;36(3):159-70
pubmed: 23502763
Blood. 2004 Nov 1;104(9):2840-8
pubmed: 15238416
Sci Adv. 2021 Feb 26;7(9):
pubmed: 33637530
Blood. 2000 Apr 1;95(7):2352-5
pubmed: 10733506
Cancer Res. 2009 Dec 1;69(23):9003-11
pubmed: 19903853
Immunity. 2014 Jul 17;41(1):63-74
pubmed: 24981853
J Immunol. 2010 May 1;184(9):4936-46
pubmed: 20351194
Science. 2014 May 9;344(6184):641-5
pubmed: 24812403
Oncotarget. 2018 Sep 25;9(75):34132-34141
pubmed: 30344927
Eur J Immunol. 2013 Nov;43(11):3038-50
pubmed: 23893393
J Exp Med. 2010 Mar 15;207(3):637-50
pubmed: 20156971
J Immunol. 2010 Jun 15;184(12):6569-73
pubmed: 20495070
Cancer Immunol Res. 2015 Sep;3(9):1070-81
pubmed: 25943533
Nature. 1998 Jun 4;393(6684):480-3
pubmed: 9624005
J Immunol Methods. 2019 Mar;466:1-8
pubmed: 30468736
Sci Immunol. 2019 Jan 11;4(31):
pubmed: 30635355
Clin Transl Immunology. 2020 Nov 23;9(11):e1216
pubmed: 33251011
Cell Immunol. 2009;257(1-2):69-79
pubmed: 19338979